Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO

new chief financial officer effective July 31, Google's parent company announced Tuesday, almost a year after Alphabet first announced current CFO Ruth Porat would move to a new role as president and chief investment officer.confirmed her departure.

"We're very pleased to have found such a strong CFO, with a track record of strategic focus on long-term investment to fuel innovation and growth," Alphabet CEO Sundar Pichai said in aAshkenazi joined Eli Lilly in 2001 and had been CFO since 2021. She will continue to serve on the pharmaceutical company's executive committee until her departure.

Porat had nearly three-decade career as as an investment banker at Morgan Stanley, culminating as its CFO, before joining Google in 2015. She helped Google grow into one of the most valuable companies in the world, even as it has contended with threats ranging from the AI race to antitrust investigations.

The leadership shuffle has long been in the works. Google first announced in 2023 that Porat would step down and has been mounting a search process since then. Google's finance unit has been grappling with other changes in recent months as well. Porat announced earlier this year that Google was restructuring its finance unit as the company pushed to favor investments in AI, CNBCOther top executives at the firm include chief business officer Philipp Schindler, search chief Prabhakar Raghavan and Google Cloud CEO Thomas Kurian..

Source: News Formal (newsformal.com)

Business Alphabet Inc Ruth Porat Eli Lilly And Co Breaking News: Technology Business News

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Alphabet names Eli Lilly veteran Ashkenazi as CFOAlphabet names Eli Lilly veteran Ashkenazi as CFO
Source: Investingcom - 🏆 450. / 53 Read more »

Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments.
Source: NBCDFW - 🏆 288. / 63 Read more »

Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supplyEli Lilly and Novo Nordisk are boosting supply of their weight loss drugs, while Apple Watch’s heart monitoring tech was approved for use in clinical…
Source: NBCLA - 🏆 319. / 59 Read more »

Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supplyEli Lilly and Novo Nordisk are boosting supply of their weight loss drugs, while Apple Watch’s heart monitoring tech was approved for use in clinical…
Source: nbcsandiego - 🏆 524. / 51 Read more »

Eli Lilly's diabetes drug tirzepatide gets approval in ChinaEli Lilly's diabetes drug tirzepatide gets approval in China
Source: Investingcom - 🏆 450. / 53 Read more »

Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulinsThe rivalry between Eli Lilly and Novo Nordisk extends beyond weight loss and diabetes drugs. Meanwhile, Uber has announced new features for caregivers.
Source: NBCLA - 🏆 319. / 59 Read more »